Mycobacterial Diseases

Mycobacterial Diseases
Open Access

ISSN: 2161-1068

Hoon H Sunwoo

Hoon H Sunwoo

Edmonton, Alberta, T6G 2N8

  • Review Article
    Current Overview of Anti-Tuberculosis Drugs: Metabolism and Toxicities
    Author(s): Susmita Sarkar, Advaita Ganguly and Hoon H SunwooSusmita Sarkar, Advaita Ganguly and Hoon H Sunwoo

    Tuberculosis, a global public health epidemic, is one of the leading causes of death by an infectious disease. According to the World Health Organization (WHO), one third of the world’s population is infected with Mycobacterium tuberculosis (MTb), 5-10% of whom will possibly go on to develop active disease. Tuberculosis (TB) is an epidemic especially in poor countries, and each year the disease kills approximately 1.7 million people worldwide. The Mycobacterium family has over 60 species but only a few of them can cause diseases in humans, such as Mycobacterium tuberculosis, Mycobacterium leprae, Mycobacterium africanum and Mycobacterium avium. MTb can exist in the latent state, where it resides in the human body for an extended period of time without showing any clinical symptoms. Once the host’s immune system becomes weakened, whether by age or concomita.. View More»
    DOI: 10.4172/2161-1068.1000209

    Abstract PDF

Relevant Topics